From June 23, 2022 to June 30, 2022, the company has repurchased 10,936 shares, representing 0.05% for KRW 82.05 million. With this, the company has completed the repurchase of 10,936 shares, representing 0.05% for KRW 82.05 million under the buyback announced on June 23, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,800 KRW | 0.00% | +1.37% | -16.67% |
2023 | Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 14 billion in funding | CI |
2023 | Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-16.67% | 79.38M | |
+25.64% | 45.93B | |
+36.11% | 23.66B | |
+20.20% | 14.63B | |
+68.52% | 14.22B | |
-0.05% | 6.79B | |
-11.31% | 6.3B | |
+15.48% | 5.77B | |
-8.87% | 5.73B | |
+12.06% | 4.84B |
- Stock Market
- Equities
- A002210 Stock
- News Dong Sung Bio Pharm.Co.,Ltd.
- Tranche Update on Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback Plan announced on June 23, 2022.